LumiraDx products may be covered by one or more of the following patents and patent applications:
JP6016168B, US20130309778, CN103097029, IN1657/DELNP/2013, PCT/GB2017/051946, ARP170101903, TW106123057
EP2613881, US9919313, JP6016168B, US9341620 CN103348245m EP2673643, JP5922153, US20130309778, CN103097029, IN1657/DELNP/2013, PCT/GB2017/051946, ARP170101903, TW106123057, CN103097029, IN1657/DELNP/2013, PCT/GB2017/051946, ARP170101903, TW106123057, US20160320374A1, IN5321/DELNP/2013, GB1815278.5
US9848386, US8606338, US8150424, US7937121, US7466979, US7187924
US9848386, US8606338, US8150424, US7937121, US7466979, US7187924
Supporting healthier lives, for individuals, communities and wider society
Enabling responsive, personal relationships between patients and care teams.
Controlling and reducing costs to help ease pressure on healthcare budgets.